TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease

The microglial receptors, CD33 and TREM2, have been associated with risk for Alzheimer’s disease (AD). Here, we investigated crosstalk between CD33 and TREM2. We showed that knock-out of CD33 attenuated amyloid beta (Aβ) pathology and improved cognition in 5xFAD mice, both of which were abrogated by...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuron
Autori principali: Griciuc, Ana, Patel, Shaun, Federico, Anthony N., Choi, Se Hoon, Innes, Brendan J., Oram, Mary K., Cereghetti, Gea, McGinty, Danielle, Anselmo, Anthony, Sadreyev, Ruslan I., Hickman, Suzanne E., Khoury, Joseph El, Colonna, Marco, Tanzi, Rudolph E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728215/
https://ncbi.nlm.nih.gov/pubmed/31301936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuron.2019.06.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi